Trial Profile
A Phase II Open Label Trial of PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer After Failure of At Least One Prior Chemotherapy Regimen.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Dacomitinib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 19 May 2015 Status changed from not yet recruiting to completed as per ClinicalTrials.gov record.
- 30 Jun 2010 New trial record